A Michigan man has received the new Roctavian gene therapy for hemophilia A. However, the treatment's availability is uncertain as its developer has reportedly pulled it, taking a financial loss. The gene therapy's existence suggests that treatment for hemophilia A using this method has become a reality, although its current status is unclear.